Imogen Duncan

677 total citations
9 papers, 556 citations indexed

About

Imogen Duncan is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, Imogen Duncan has authored 9 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Immunology and 3 papers in Genetics. Recurrent topics in Imogen Duncan's work include Herpesvirus Infections and Treatments (4 papers), Virus-based gene therapy research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Imogen Duncan is often cited by papers focused on Herpesvirus Infections and Treatments (4 papers), Virus-based gene therapy research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Imogen Duncan collaborates with scholars based in United Kingdom, Slovakia and Germany. Imogen Duncan's co-authors include C. S. McLean, M. E. G. Boursnell, Stephen Inglis, R. Jennings, R M Binns, Geoffrey W. Butcher, Amanda Hutchings, Simon J. Powis, Murat Ertürk and A. C. Minson and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The Journal of Infectious Diseases and Journal of Leukocyte Biology.

In The Last Decade

Imogen Duncan

9 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imogen Duncan United Kingdom 9 285 228 130 79 79 9 556
Gregory C. Wipf United States 12 675 2.4× 207 0.9× 112 0.9× 117 1.5× 53 0.7× 13 917
J. C. M. Macnab United Kingdom 16 650 2.3× 116 0.5× 318 2.4× 203 2.6× 76 1.0× 43 836
R. L. Heberling United States 12 177 0.6× 134 0.6× 142 1.1× 131 1.7× 88 1.1× 36 534
Punee Pitisuttithum Thailand 6 412 1.4× 94 0.4× 160 1.2× 123 1.6× 26 0.3× 10 660
R Pu United States 7 467 1.6× 328 1.4× 151 1.2× 71 0.9× 18 0.2× 8 846
B Nonnenmacher Brazil 7 748 2.6× 294 1.3× 142 1.1× 94 1.2× 89 1.1× 7 857
Sara L. Bissett United Kingdom 13 397 1.4× 139 0.6× 55 0.4× 58 0.7× 49 0.6× 23 495
Brigitte Colau Netherlands 11 776 2.7× 252 1.1× 42 0.3× 278 3.5× 51 0.6× 16 1.0k
S. Ghim United States 11 669 2.3× 343 1.5× 192 1.5× 125 1.6× 94 1.2× 18 879
Eva-Liz Johansson Sweden 8 243 0.9× 461 2.0× 35 0.3× 145 1.8× 21 0.3× 9 818

Countries citing papers authored by Imogen Duncan

Since Specialization
Citations

This map shows the geographic impact of Imogen Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imogen Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imogen Duncan more than expected).

Fields of papers citing papers by Imogen Duncan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imogen Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imogen Duncan. The network helps show where Imogen Duncan may publish in the future.

Co-authorship network of co-authors of Imogen Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of Imogen Duncan. A scholar is included among the top collaborators of Imogen Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imogen Duncan. Imogen Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Abbas, Yassen, Lucia G. Brunel, Michael Hollinshead, et al.. (2020). Generation of a three-dimensional collagen scaffold-based model of the human endometrium. Interface Focus. 10(2). 20190079–20190079. 88 indexed citations
2.
Duncan, Imogen, et al.. (2002). In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions. Journal of Leukocyte Biology. 72(3). 522–529. 21 indexed citations
3.
Loudon, Peter T., D M Blakeley, M. E. G. Boursnell, et al.. (2001). Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients. The Journal of Gene Medicine. 3(5). 458–467. 15 indexed citations
4.
Boursnell, M. E. G., Claire Entwisle, D M Blakeley, et al.. (1997). A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease. The Journal of Infectious Diseases. 175(1). 16–25. 135 indexed citations
5.
McLean, C. S., et al.. (1996). Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine. Vaccine. 14(10). 987–992. 48 indexed citations
6.
McLean, C. S., Murat Ertürk, R. Jennings, et al.. (1994). Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1. The Journal of Infectious Diseases. 170(5). 1100–1109. 110 indexed citations
7.
Binns, R M, Imogen Duncan, Simon J. Powis, Amanda Hutchings, & Geoffrey W. Butcher. (1992). Subsets of null and gamma delta T-cell receptor+ T lymphocytes in the blood of young pigs identified by specific monoclonal antibodies.. PubMed. 77(2). 219–27. 94 indexed citations
8.
Duncan, Imogen, R M Binns, & W. P. H. Duffus. (1989). The null T cell in pig blood is not an NK cell.. PubMed. 68(3). 392–5. 15 indexed citations
9.
Schmitz, Brigitte, Roger A. Klein, Imogen Duncan, et al.. (1987). MS and NMR analysis of the cross-reacting determinant glycan from Trypanosoma brucei brucei MITat 1.6 variant specific glycoprotein. Biochemical and Biophysical Research Communications. 146(3). 1055–1063. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026